Home » Topics » Regulatory

Regulatory
RSS

FDA actively reviewing TOBI

Oct. 13, 1997

CellPro seeks new indication for CEPRATE SC System

Oct. 13, 1997

Oral desmopressin evaluated in bed-wetting children

Oct. 13, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

FDA approval granted for Carbatrol

Oct. 10, 1997

Nastech files IND for new formulation of buprenorphine

Oct. 10, 1997

TheraTech joins forces with Meiji and Sankyo to develop and market oxybutynin patch

Oct. 10, 1997

Pamidronate evaluated as potential therapy for bone cancer

Oct. 9, 1997

Celgene studies chirally pure mexiletine for relief of neuropathic pain

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...